Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06150599 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sacral Neuromodulation for Chronic Pelvic Pain

Study acronym: SNM_CPP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 30, 2025 to Jan 27, 2026v11
  2. Site contact updatedv10
  3. Start date changed from estimate of Oct 30, 2025 to Jun 30, 2025v9
  4. Primary completion date: May 2026 to Apr 1, 2028
    • Start date: Jun 2025 to Oct 30, 2025
    • Study completion date: Jun 2028 to Dec 1, 2028
    v8
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Mar 2025 to Jun 2025
    • Study site revised
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Start date: Dec 2024 to Mar 2025
    • Primary completion date: Dec 2026 to May 2026
    • Study completion date: Dec 2028 to Jun 2028
    v6
  2. Eligibility criteria expanded, about 72 words
    • Secondary endpoints: details revised at 1 of 9 entries
    v5
  3. Primary completion date: Dec 2025 to Dec 2026
    • Start date: Jul 2024 to Dec 2024
    • Study completion date: Dec 2027 to Dec 2028
    v4
  4. Primary completion date: Apr 2025 to Dec 2025
    • Start date: Apr 2024 to Jul 2024
    • Study completion date: Mar 2027 to Dec 2027
    v3
  5. Primary completion date: Mar 2024 to Apr 2025
    • Start date: Dec 2023 to Apr 2024
    • Study completion date: Mar 2026 to Mar 2027
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with suffering from chronic pelvic pain (CPP), through a single device implant procedure.
Trial Details
NCT Number NCT06150599
Lead Sponsor Corewell Health East
Conditions
(from sponsor)		 Chronic Pelvic Pain Syndrome
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov